MPH MD - Scholar Rock CEO President

SRRK Stock  USD 39.90  1.75  4.59%   

CEO

MPH MD is CEO President of Scholar Rock Holding
Age 69
Address 301 Binney Street, Cambridge, MA, United States, 02142
Phone857 259 3860
Webhttps://scholarrock.com

Scholar Rock Management Efficiency

The company has return on total asset (ROA) of (0.671) % which means that it has lost $0.671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8307) %, meaning that it created substantial loss on money invested by shareholders. Scholar Rock's management efficiency ratios could be used to measure how well Scholar Rock manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.56. The value of Return On Capital Employed is expected to slide to -0.65. At this time, Scholar Rock's Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 53.2 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 252.2 M.
Scholar Rock Holding currently holds 61.82 M in liabilities with Debt to Equity (D/E) ratio of 0.22, which may suggest the company is not taking enough advantage from borrowing. Scholar Rock Holding has a current ratio of 9.5, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Scholar Rock's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 10 records

CEO Age

Mark ManfrediIkena Oncology
53
Jon CongletonMineralys Therapeutics, Common
61
Sarah BoyceAvidity Biosciences
52
William MDPassage Bio
51
Fred JDIGM Biosciences
71
Nadim AhmedCullinan Oncology LLC
56
Alexandria ForbesMeiraGTx Holdings PLC
59
Markus MDMonte Rosa Therapeutics
53
John HoustonArvinas
64
Mark GoldsmithRevolution Medicines
62
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Scholar Rock operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 145 people. Scholar Rock Holding (SRRK) is traded on NASDAQ Exchange in USA. It is located in 301 Binney Street, Cambridge, MA, United States, 02142 and employs 150 people. Scholar Rock is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Scholar Rock Holding Leadership Team

Elected by the shareholders, the Scholar Rock's board of directors comprises two types of representatives: Scholar Rock inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scholar. The board's role is to monitor Scholar Rock's management team and ensure that shareholders' interests are well served. Scholar Rock's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scholar Rock's outside directors are responsible for providing unbiased perspectives on the board's policies.
Erin CPA, Senior Finance
Junlin JD, General Secretary
Erin Moore, Senior Finance
Catherine Hu, IR Contact Officer
Caryn Parlavecchio, Chief Officer
Lisa Price, Senior Resources
MBA MD, Chief Officer
Mo Qatanani, Senior Research
Edward MBA, COO CFO
Rushmie Nofsinger, Vice Relations
Ryan Iarrobino, Senior Operations
MBA MBA, COO CFO
MPH MD, CEO President
Tracey MBA, Chief Officer

Scholar Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scholar Rock a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Scholar Rock Holding is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Scholar Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Scholar Rock Holding Stock. Highlighted below are key reports to facilitate an investment decision about Scholar Rock Holding Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scholar Rock Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scholar Rock. If investors know Scholar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scholar Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.36)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.67)
Return On Equity
(1.83)
The market value of Scholar Rock Holding is measured differently than its book value, which is the value of Scholar that is recorded on the company's balance sheet. Investors also form their own opinion of Scholar Rock's value that differs from its market value or its book value, called intrinsic value, which is Scholar Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scholar Rock's market value can be influenced by many factors that don't directly affect Scholar Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scholar Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scholar Rock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scholar Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.